"The Organic Chemistry of Drug Design and Drug Action, Third
Edition," represents a unique approach to medicinal chemistry based
on physical organic chemical principles and reaction mechanisms
that rationalize drug action, which allows the reader to
extrapolate those core principles and mechanisms to many related
classes of drug molecules. This new edition reflects significant
changes in the process of drug design over the last decade. It
preserves the successful approach of the previous editions while
including significant changes in format and coverage.
New to this edition: Updates to all chapters, including new
examples and referencesChapter 1 (Introduction): Completely
rewritten and expanded as an overview of topics discussed in detail
throughout the bookChapter 2 (Lead Discovery and Lead
Modification): Sections on sources of compounds for screening
including library collections, virtual screening, and computational
methods, as well as hit-to-lead and scaffold hopping; expanded
sections on sources of lead compounds, fragment-based lead
discovery, and molecular graphics; and deemphasized solid-phase
synthesis and combinatorial chemistryChapter 3 (Receptors):
Drug-receptor interactions, cation-p and halogen bonding;
atropisomers; case history of the insomnia drug suvorexantChapter 4
(Enzymes): Expanded sections on enzyme catalysis in drug discovery
and enzyme synthesisChapter 5 (Enzyme Inhibition and Inactivation):
New case histories: for competitive inhibition, the epidermal
growth factor receptor tyrosine kinase inhibitor, erlotinib and
Abelson kinase inhibitor, imatinibfor transition state analogue
inhibition, the purine nucleoside phosphorylase inhibitors,
forodesine and DADMe-ImmH, as well as the mechanism of the
multisubstrate analog inhibitor isoniazidfor slow, tight-binding
inhibition, the dipeptidyl peptidase-4 inhibitor,
saxagliptinChapter 7 (Drug Resistance and Drug Synergism): This new
chapter includes topics taken from two chapters in the previous
edition, with many new examplesChapter 8 (Drug Metabolism):
Discussions of toxicophores and reactive metabolitesChapter 9
(Prodrugs and Drug Delivery Systems): Discussion of antibody-drug
conjugates
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!